Vldlr overexpression causes hyperactivity in rats by Keiko Iwata et al.
Iwata et al. Molecular Autism 2012, 3:11
http://www.molecularautism.com/content/3/1/11RESEARCH Open AccessVldlr overexpression causes hyperactivity in rats
Keiko Iwata1†, Nobuo Izumo2†, Hideo Matsuzaki1*, Takayuki Manabe3, Yukiko Ishibashi4, Yukio Ichitani5,
Kazuo Yamada5, Ismail Thanseem6, Ayyappan Anitha1, Mahesh Mundalil Vasu6, Chie Shimmura6,
Tomoyasu Wakuda6, Yosuke Kameno6, Taro Takahashi1, Yasuhide Iwata6, Katsuaki Suzuki1, Kazuhiko Nakamura6
and Norio Mori6Abstract
Background: Reelin regulates neuronal positioning in cortical brain structures and neuronal migration via binding
to the lipoprotein receptors Vldlr and Lrp8. Reeler mutant mice display severe brain morphological defects and
behavioral abnormalities. Several reports have implicated reelin signaling in the etiology of neurodevelopmental
and psychiatric disorders, including autism, schizophrenia, bipolar disorder, and depression. Moreover, it has been
reported that VLDLR mRNA levels are increased in the post-mortem brain of autistic patients.
Methods: We generated transgenic (Tg) rats overexpressing Vldlr, and examined their histological and behavioral
features.
Results: Spontaneous locomotor activity was significantly increased in Tg rats, without detectable changes in brain
histology. Additionally, Tg rats tended to show performance deficits in the radial maze task, suggesting that their
spatial working memory was slightly impaired. Thus, Vldlr levels may be involved in determining locomotor activity
and memory function.
Conclusions: Unlike reeler mice, patients with neurodevelopmental or psychiatric disorders do not show striking
neuroanatomical aberrations. Therefore, it is notable, from a clinical point of view, that we observed behavioral
phenotypes in Vldlr-Tg rats in the absence of neuroanatomical abnormalities.
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Reelin, a large secreted glycoprotein, is critical for nor-
mal brain development [1-3]. During embryonic devel-
opment, reelin is secreted by specialized Cajal-Retzius
cells to form a highly laminated structure in the neocor-
tex, hippocampus, and cerebellum [2,4-6]. The reelin
signaling pathway involves two reelin receptors, very-
low-density lipoprotein receptor (Vldlr) and low-density
lipoprotein receptor-related protein 8 (Lrp8), and the
intracellular adaptor protein, disabled homolog 1 (Dab1)
[7-9].
A number of studies have reported that reelin signal-
ing is involved in the dopaminergic system, especially
the expression of dopamine receptors in the nucleus* Correspondence: matsu@hama-med.ac.jp
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reproduction in any medium, provided the oraccumbens [10,11]. Moreover, considerable evidence has
implicated nucleus accumbens dopamine in the regula-
tion of locomotor activity [12-17]. Additionally, recent
studies have demonstrated the necessity for reelin signal-
ing in certain aspects of hippocampal synaptic function,
the formation of some forms of mammalian memory,
and cognitive function [18-26].
Several reports implicate reelin signaling in the eti-
ology of neurodevelopmental and psychiatric disor-
ders, including autism, schizophrenia, bipolar disorder,
and depression [27-35]. Post-mortem studies have
reported decreased levels of reelin and its message in
patients with autism, schizophrenia, and bipolar dis-
order, with less consistent findings for depression
[27,29,30,32,33,36]. The finding of reduced reelin levels
in these disorders has prompted interest in the reeler
mutant mouse, which has a spontaneous mutation in
the reelin gene, as an animal model of neurodevelop-
mental and psychiatric disorders. Homozygous reelertd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ance, and a reeling gait, associated with severe hypopla-
sia of the cerebellum and neuronal ectopia in laminated
brain regions [2]. Owing to the severe gait defects, it is
difficult to evaluate other behavioral phenotypes. Het-
erozygous mice do not show obvious defects: two
detailed studies have reported no defects in the behav-
ioral phenotype of heterozygous mice [37,38], although a
subsequent study reported deficits in contextual fear
conditioning [39].
Fatemi et al. reported that post-mortem VLDLR
mRNA levels are increased in the brain of autistic
patients [29]. Furthermore, it has been reported that
psychotropic drug treatment changes Vldlr expression in
the rat brain [40]. However, little attention has been
given to increased Vldlr expression. In this study, we
generated transgenic (Tg) rats overexpressing Vldlr, and
examined their histological and behavioral features.Methods
All experiments were approved by the Committee on
Animal Research of Hamamatsu University School of
Medicine, Yokohama College of Pharmacy and Univer-
sity of Tsukuba. All experiments were performed in ac-
cordance with the Guide for Animal Experimentation at
the Hamamatsu University School of Medicine, Yokohama
College of Pharmacy and University of Tsukuba.Generation of Vldlr transgenic rats
The full-length rat Vldlr complementary DNA (cDNA)
was obtained from Dr. Masuzaki (University of the
Ryukyus) [41]. The Vldlr cDNA was subcloned into the
pIRES vector (Takara Bio, Inc., Otsu, Japan). The Vldlr
internal ribosome entry site (IRES) was subsequently sub-
cloned into the pCX-EGFP vector containing the CMV
immediate-early enhancer (CMV-IE)/chicken β-actin pro-
moter and enhanced green fluorescent protein (EGFP).
The identity of the cloned gene was verified by DNA se-
quence analysis. Transgenic rats were generated by micro-
injection of a 6.3-kb Sal I/Bsa BI fragment (Figure 1A),
from the expression vector pCX-Vldlr-IRES-EGFP, into
the pronuclei of fertilized eggs. The injected embryos
were transferred to pseudopregnant female Sprague–
Dawley rats. Transgenic founders were identified by
whole-body EGFP fluorescence and PCR using primers
for Vldlr exon 5 (F: 50-TTGTGTGCAATGGACAGGAT-
30) and exon 6 (R: 50-CTTCATCAGAGCCGTCAACA-
30). This primer pair can distinguish the Vldlr transgene
(a 417-bp fragment) from endogenous Vldlr (a 502-bp
fragment) (Figure 1B). Three EGFP- and transgene-
positive founders were obtained, but overexpression was
confirmed in only one founder (Figures 2C,D). Thus, all
studies were performed in a line derived from thisfounder. Unless otherwise stated, adult (2 to 3 months)
rats were used for experiments.RNA isolation and quantitative real-time reverse-
transcription-polymerase chain reaction
Total RNA was isolated from whole brain or specific
brain regions, using TRIZOL Reagent (Invitrogen,
Carlsbad, CA), and reverse transcribed using the Super-
Script III First-Strand Synthesis System (Invitrogen).
cDNA was used for qRT-PCR, which was performed
using the SYBR GREEN PCR Master Mix (Qiagen,
Hilden, Germany). Actb expression was used as a control
for mRNA expression. Gene expression changes were quan-
tified using the delta-delta CT method. The primer sequences
were as follows: Vldlr sense, 50-TTCACATCCTCCATTCT
CCA-30; antisense, 50-CAATCTCAATGATGCCCAAG-30;
Dab1 sense, 50-GCTTTGAAAGTCCCAGCAAG-30; 50-anti-
sense, ATGGATCACTGGTGGAGGAG-30; Actb sense, 50-
CGTGAAAAGATGACCCAGATCA-30; antisense, 50-AGA
GGCATACAGGGACAACACA-30.Membrane preparation
Rat livers were dissected in 0.9% NaCl at postnatal day 0
(P0). Tissues were placed in ice-cold homogenization
buffer containing 0.32 M sucrose, 3 mM HEPES (pH 7.3)
and a protease inhibitor Complete Mini tablet (Roche
Diagnostics, Mannheim, Germany), for homogenization.
Total lysates were centrifuged at 1,000g for 10 min at 4°C.
The supernatants were collected and centrifuged at
20,000g for 30 min at 4°C. The pellets, containing the
membrane fractions, were resuspended in 10% sodium
dodecyl sulfate (SDS). The protein concentration in the
membrane fractions was measured and normalized to
10% SDS.Western blot analysis
Membrane fractions (70 μg) were subjected to 7.5%
SDS-polyacrylamide gel electrophoresis, followed by
blotting to a polyvinylidene fluoride membrane (GE
Healthcare, Little Chalfont, UK). The transferred mem-
branes were incubated with a primary antibody against
Vldlr (1:200; 6A6, Santa Cruz Biotechnology, Inc., Santa
Cruz, CA) or β-actin (1:4,000; Abcam, Inc., Cambridge,
MA) at 4°C overnight. After incubation, the membranes
were washed three times with phosphate-buffered saline
without Mg2+ or Ca2+ (PBS(−)), containing 0.1% Tween-
20, and were then incubated with the appropriate sec-
ondary antibody (1:20,000) at room temperature for 1 h.
The membranes were washed with PBS(−) containing
0.1% Tween-20, followed by visualization using an
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Figure 1 Generation of Vldlr transgenic (Tg) rats. (A) Map of Vldlr genomic DNA and the pCX-Vldlr-IRES-EGFP transgene. Full-length rat Vldlr
cDNA was subcloned into the pIRES vector. The Vldlr internal ribosome entry site (IRES) was then subcloned into the pCX-EGFP vector containing
the CMV immediate-early enhancer (CMV-IE)/chicken β-actin promoter and enhanced green fluorescent protein (EGFP). Arrows show positions of
the PCR primers used to distinguish genomic DNA from the transgene. (B) PCR-based genotyping of transgenic rats. The primers identified a 502-
bp wild-type (Wt) genomic DNA fragment and a 417-bp transgene (Tg) fragment. (C) Expression of endogenous (Wt) and transgenic (Tg) Vldlr
protein in the liver at P0. Two pups from each line (1 to 3) were used. Vldlr from membrane fractions was detected by Western blotting using an
anti-Vldlr antibody (upper panel). The blots were subsequently probed with an anti-β-actin antibody as a protein loading control (lower panel).
The results are representative of three independent experiments. (D) qRT-PCR quantification of Vldlr mRNA expression in Wt and Tg whole brain
at P0 (lines 1–3). (E) qRT-PCR quantification of Vldlr mRNA expression in Wt and Tg whole brain (upper panel), and prefrontal cortex,
hippocampus and cerebellum (lower panels) in adult (2 to 3 months) rats from transgenic line 1. Relative Vldlr expression was obtained by
normalizing to Actb from the same cDNA. Results are expressed as a ratio of Wt expression, resulting in a Wt ratio of 1. Error bars represent mean
± SEM (n = 3 to 6 per genotype). * P < 0.05, ** P < 0.01 between Wt and Tg rats.
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Rats were anesthetized and perfused with 4% parafor-
maldehyde in PBS(−). The brains were removed and
postfixed in the same fixative at 4°C, then transferred to
30% sucrose in PBS(−). When they sank, the brains were
embedded in OCT compound (Tissue Tek, SakuraFinetek USA Inc., Torrance, CA) and frozen on pow-
dered dry ice. Serial sections (30 μm) were cut and
floated in PBS(−). The first series sections were stained
with cresyl violet for Nissl staining. The second series
sections were incubated overnight at 4°C with anti-









































Figure 2 Effect of Vldlr overexpression on Dab1 mRNA expression. qRT-PCR quantification of Dab1 mRNA expression in prefrontal cortex,
hippocampus and cerebellum of wild-type (Wt) and transgenic (Tg) adult (2 to 3 months) rats from transgenic line 1. Relative Dab1 expression
was obtained by normalizing to Actb from the same cDNA. The results are expressed as a ratio of Wt expression, resulting in a Wt ratio of 1. Bars
represent mean ± SEM (n = 6 per genotype). * P < 0.05 between Wt and Tg rats.
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were then washed and incubated with biotin-conjugated
anti-mouse IgG (1:200, Vector Laboratories, Burlingame,
CA) for 1 h at room temperature. After washing, the
sections were processed for 1 h using a Vectastain ABC
kit (Vector Laboratories). Staining was visualized with
diaminobenzidine (Vector Laboratories) as the chro-
matic agent. Control slices were incubated as described,
but without primary antibody. No immunoreactivity was
seen in the controls (data not shown).
Behavioral tests
Open-field test
The open-field test is one of the best established ways to
test exploratory locomotor activity in a novel environ-
ment. A square open field (90 cm × 90 cm) was con-
structed from gray polyamide enclosed by a 40 cm high
surrounding wall. Each open field was divided into cen-
tral (30 cm × 30 cm) and outer areas. The 15-min test
was started after placing each rat individually in the
same corner facing the wall. Behavior was recorded, and
distance traveled (cm) and time spent in the central area
(s) were analyzed, using the video-tracking system
Viewer (version 2.2; Neuroscience, Inc., Tokyo, Japan).
Spontaneous locomotor activity test
To measure spontaneous locomotor activity, a rat was
placed in a plastic cage (24.5 cm × 40 cm × 20 cm) with
clean paper, food, and water. To ensure that the novelty
of the cage did not confound the activity measure-
ments, the first 17 hours of activity were not analyzed.
Locomotion was measured per hour throughout the
whole day using a digital counter with an infrared sen-
sor (NS-AS01; Neuroscience, Inc.). The room light was
on from 7:00 a.m. to 7:00 p.m.
Radial maze test
This test used an elevated eight-arm radial maze made
of black polyvinyl chloride. The maze consisted of an oc-
tagonal central platform (32 cm in diameter) and eightarms (60 cm × 12 cm) radiating from the platform. A
food well (1 cm in diameter, 0.5 cm deep) was carved
out at the end of each arm. Plexiglas guillotine doors
(15 cm high) divided the arms from the central plat-
form, and each was operated automatically. The sidewalls
of the arms were 4 cm high, except 12 cm from guillotine
doors, where they were 12 cm high. The maze was ele-
vated 70 cm above the floor. There were extra-maze vis-
ual cues (for example, a curtain, a desk, colored drawing
paper, and a door) around the maze. Control and analysis
of the behavioral experiment was carried out using Image
RM (O’Hara Co., Ltd, Tokyo, Japan), a modified version
of the free software NIH Image (National Institutes of
Health, Bethesda, MD).
Rats were given 5 min handling for three days and
then three daily sessions of habituation to the apparatus.
In the habituation session, all the guillotine doors were
opened and 20 mg food pellets (Research Diets, Inc.,
New Brunswick NJ) were placed on the platform and
arms. In the first two sessions, five rats were placed in
the maze together for 30 min, and in the last session,
each rat was placed in the maze individually for 15 min.
Rats were trained on the radial maze task for one trial a
day. At the beginning of each trial, a 20 mg food pellet
was placed in each food well. The rat was placed on the
central platform and all the doors were opened. A choice
was counted when the rat completely entered an arm;
then all the doors except that of the chosen arm were
closed. When the rat returned to the central platform,
the door was closed and the rat confined there for 5 s.
After that, all the doors were reopened and the rat was
allowed the next choice. This procedure was repeated
until the animal had consumed all the pellets, it had
made 16 choices, or 10 min had elapsed since the start
of the trial. A correct choice was defined when the rat
entered an arm that had not previously been entered
during the trial or in which the pellet had not been con-
sumed; the other choices were counted as errors. The
learning criterion was defined as five consecutive trials
in which seven or more correct choices, in the first eight
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recorded.
Social interaction test
Social interaction was tested in the same apparatus used
for the open-field test. Each rat was tested for 15 min
with a weight-matched partner from a different home
cage. Social interaction was assessed by the time spent
interacting, including sniffing, following, crawling over
or under, grooming, and aggressive behaviors.
Elevated plus maze test
The elevated plus maze is a well-established model to
assess the level of anxiety in rodents. The apparatus was
made of gray polyamide and comprised two open arms
(50 cm × 9 cm), two enclosed arms (50 cm × 9 cm ×
50 cm), and a central platform (8.5 cm × 8.5 cm). The ap-
paratus was elevated 50 cm above the floor. At the begin-
ning of the test, the rats were placed on the central
platform facing the same open arm. The test lasted 10 min
and the behavior of the rat was recorded; the time spent
in the closed and open arms was analyzed by a video-
tracking system, as described.
Statistical analyses
Statistical significance of Vldlr and Dab1 mRNA levels
were analyzed using unpaired Student’s t tests, after it
had been confirmed that there were no statistically sig-
nificant differences in variance, as assessed by the F test.
Repeated measures analyses of variance (ANOVA) and
unpaired Student’s t tests were used for analysis of the
behavioral tests.
Results
Generation of Vldlr transgenic rats
To evaluate the effects of increasing Vldlr expression in
rats, we generated Tg rats harboring a Sal I/Bsa BI frag-
ment from the expression vector pCX-Vldlr-IRES-EGFP
(Figure 1A). Three transgenic founders were identified by
PCR and whole-body EGFP fluorescence. The growth pat-
terns of all founders and non-transgenic (wild-type, Wt)
littermates were similar, indicating no severe effect of the
Vldlr transgene in terms of growth of the Tg rats. All
founders gave rise to true-breeding lines (lines 1, 2, and 3),
and transmitted the transgene and EGFP fluorescence to
their offspring. Both males and females reproduced at a
rate similar to that of their Wt littermates, and their off-
spring grew normally.
First, we examined whether exogenous Vldlr was
expressed at the plasma membrane in Tg rats. Vldlr is
not expressed endogenously in rat liver [42]. Therefore,
we collected membrane fractions from the livers of two
pups, from each line, and examined Vldlr expression by
Western blotting. Vldlr protein was strongly detected inline 1 pups, whereas the expression was very weak in
line 2 and 3 pups (Figure 1C). Second, we confirmed
overexpression of Vldlr mRNA in the whole brain by
qRT-PCR. An approximately 1.5-fold increase in Vldlr
mRNA was detected (Figure 1D) in line 1 Tg rats, com-
pared with Wt rats, at P0 (P < 0.01). However, there was
no significant increase in mRNA levels in lines 2 or 3.
In line 1, Vldlr overexpression was detected in the
adult (2 to 3 months) brain, at the same level as at
P0 (P < 0.01; Figure 1E, upper graph). In addition, we
measured Vldlr mRNA in multiple brain regions of rele-
vance to autism, including the prefrontal cortex, hippocam-
pus, and cerebellum, using adult rats. Vldlr expression
levels were increased in these regions 1.3-, 1.2- and 1.6-fold,
respectively, in Tg rats compared with Wt rats (P < 0.01,
P < 0.05 and P < 0.01, respectively; Figure 1E, lower
graphs). Thus, in transgenic line 1, Vldlr is stably overex-
pressed, including in brain regions relevant to autism. Fi-
nally, we investigated whether downstream signaling
pathways are altered by Vldlr overexpression. The tyrosine
residue of Dab1 is phosphorylated, following reelin binding
to Vldlr [8]. It has been suggested that Dab1 phosphoryl-
ation causes a reduction in Dab1 protein levels via a nega-
tive feedback circuit [43]. Moreover, Fatemi et al. have
reported increased VLDLR and reduced DAB1 mRNA
levels in post-mortem brain tissue (prefrontal cortex area 9
and cerebellum) from patients with autism [29]. Therefore,
we measured Dab1 mRNA expression in the prefrontal
cortex, hippocampus, and cerebellum of adult rats. In Tg
rats, Dab1 expression levels were decreased in prefrontal
cortex and cerebellum by 0.89- and 0.67-fold, respectively,
compared with Wt rats (P < 0.05; Figure 2). However,
there was no significant decrease in mRNA levels in the
hippocampus, potentially driven by a reduced rate of
Vldlr accumulation in hippocampus compared to pre-
frontal cortex or cerebellum. Overall, our results show
that Vldlr overexpression changes downstream reelin
signaling in Tg rats, at least in the prefrontal cortex and
cerebellum. Moreover, Tg rats show abnormal expres-
sion of Vldlr and Dab1 mRNA, as detected in post-
mortem brain from patients with autism. Based on our
expression results, we chose transgenic line 1 for further
analysis.
No abnormal brain morphology in Vldlr-Tg rats
Reelin regulates neuronal positioning in brain structures,
including the neocortex, hippocampus and cerebellum.
The effects of increased Vldlr on brain morphology have
not previously been studied. We examined these brain
structures in adult Tg rats, using Nissl staining
(Figure 3A) and immunostaining with the neuronal mar-
ker, NeuN (Figure 3B). The neurons were layered nor-
mally in the neocortex and hippocampus, and the

















Figure 3 Neuroanatomical characterization of Vldlr transgenic
(Tg) rats. (A) Histology of the hippocampus and cerebellum in adult
(2 to 3 months) wild-type (Wt) and transgenic (Tg) rats. Panels show
Nissl-stained coronal sections of the hippocampus or sagittal
sections of the cerebellum. The results are representative of three
independent experiments. Scale bars, 1 mm. (B) Cortical layering in
adult (2 to 3 months) Wt and Tg rats. Panels show
immunohistochemical NeuN staining. Cortical layers are numbered I
to VI. The results are representative of three independent
experiments (Additional file 3: Supplementary method). Scale bar,
100 μm.
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each cortical layer did not change significantly in Tg rats
compared with Wt rats (Additional file 1: Figure S1).
There were no abnormalities in other brain areas in
which reelin signaling is not involved (data not shown).
Moreover, there were no histological abnormalities in the
neocortex, hippocampus, cerebellum (Additional file 2:
Figure S2), or other brain areas examined (data not
shown) at P0.
Vldlr-Tg rats show hyperactivity and memory impairment
We evaluated the effects of increased Vldlr on rat beha-
vior. Adult (2 to 3 months) rats were used for all beha-
vioral tests. First, we used the open-field test to
investigate basic behaviors and exploratory locomotor
activity in a novel environment. The total distance
moved was evaluated as motor activity, and the time
spent in the central area was evaluated as exploratory
behavior. We did not find any significant difference in
total distance moved (Figure 4A) or time spent in the
center (Figure 4B), between Tg and Wt rats. Secondly,
we measured spontaneous locomotor activity in a fami-
liar home cage. Activity was significantly increased in Tg
rats compared with Wt rats (P < 0.05, repeated measures
ANOVA; Figure 4C). Increased activity was seen in both
the dark and light phases (P < 0.05; Figure 4D), and Tg
rats were hyperactive all the time. Thirdly, we assessed
spatial working memory using an eight-arm radial maze.
The time course of the number of correct choices
among the first eight choices is shown (Figure 3E).
Transgenic rats showed a trend toward fewer correct
choices than Wt rats (P = 0.091, repeated measures
ANOVA; Figure 4E). Finally, we conducted the socialinteraction test and elevated plus maze test to evaluate
sociality and anxiety, respectively. We found no signifi-
cant difference between Wt and Tg rats (Figure 4F–H).Discussion
We have developed a rat model in which the Vldlr
transgene is driven by a strong ubiquitous promoter, to
test the in vivo neurological effects of Vldlr overexpres-
sion. Vldlr overexpression changed downstream reelin
signaling in Tg rats, as determined by reduced Dab1 ex-
pression. Moreover, Tg rats showed abnormalities in
Vldlr and Dab1 mRNA expression, similar to those
detected in post-mortem brain from patients with aut-
ism [30]. We found that spontaneous locomotor activity
was significantly increased, and a tendency toward
impaired memory function in Tg rats, without changes
in histology.
In Vldlr knockout mice, the most remarkable histo-
logical phenotype is a smaller and less foliated cerebel-
lum, with slight abnormalities found in the hippocampus
and neuronal layers of the cerebral cortex [44]. In con-
trast, in Vldlr-Tg rats, there were no histological abnor-
malities, even in the cerebellum. This suggests that a
1.5-fold increase in Vldlr may not be sufficient to affect
brain morphology.
The mechanism for the hyperactivity in the Tg rats is
unclear. It has been reported that the SH3-domain kin-
ase binding protein 1 (Sh3kbp1), which is involved in re-
ceptor endocytosis, binds Dab1, a downstream molecule
in reelin signaling. The resulting interaction may play a
role in the endocytosis of reelin receptors including
Vldlr, and cause downregulation of reelin signaling [45].
Interestingly, Sh3kbp1 knockout mice display hyper-
activity [46]. Additionally, they display abnormally high
levels of dopamine and D2 dopamine receptors in the
striatum [46]. Similarly, several studies have reported
that reelin signaling is involved in dopamine receptor
expression in the striatum [10,11]. Although there has
been no report of Vldlr expression in Sh3kbp1 knockout
mice, it is feasible that membrane expression of Vldlr is
upregulated, resulting in facilitation of the dopaminergic
system and hyperactivity in the mice. This suggests that
Vldlr regulates the dopaminergic system, and may cause
the hyperactivity observed in the Tg rats.
The spontaneous social interaction test that we used
in this study is a standard test used to measure social
interaction between animals. Using this test enabled us
to examine other social behaviors, such as aggression,
without performing additional behavioral tests. In the
course of our testing, we ascertained aggressive behavior,
and found Vldlr-Tg rats not to be aggressive (data not
shown). We did not apply other tests to measure social
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Figure 4 Behavioral effects of Vldlr overexpression. Adult (2 to 3 months) rats were used for all behavioral tests. (A,B) Open-field test. There
was no significant difference between transgenic (Tg) and wild-type (Wt) rats in total distance moved (A) or time spent in the central area (B),
n = 10 per genotype. (C,D) Locomotor activity in the home cage. Dark- (19:00 to 07:00) and light- (07:00 to 19:00) phase locomotor activity (C).
Transgenic rats were significantly more active than Wt rats (P < 0.05, repeated measures ANOVA, n = 10 or 11 per genotype). Mean dark- and
light-phase locomotor activity (D). Transgenic rats were significantly more active than Wt rats in both phases (* P < 0.05, unpaired Student’s t-test,
n = 8 to 10 per genotype). (E) Radial maze test. Number of correct choices, among the first eight choices, during learning. Transgenic rats made
fewer correct choices than Wt rats did (P = 0.091, repeated measures ANOVA, n = 8 per genotype). (F) Social interaction test. There was no
significant difference between Tg and Wt rats for the total duration of contact. n = 10 per genotype. (G,H) Elevated plus maze test. There was no
significant difference between Tg and Wt rats for the time spent in the closed arms (G) or the open arms (H). n = 10 per genotype. Error bars
represent mean ± SEM.
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ferences in some domains of social behavior.
Conclusions
Several reports have implicated reelin signaling in the
etiology of neurodevelopmental and psychiatric disor-
ders [27-35]. However, patients with these disorders do
not show striking neuroanatomical aberrations. Forexample, although post-mortem and structural magnetic
resonance imaging have highlighted the frontal lobes,
amygdala, and cerebellum as pathologically affected in
autism, there is no clear and consistent pathology for
this disorder [47]. Notably, hyperactivity and working
memory impairment are symptoms observed in neuro-
developmental and psychiatric disorders, including aut-
ism [48]. Therefore, our findings of hyperactivity and
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relevant, from a clinical point of view.
Additional files
Additional file 1: Figure S1. Neuron number and thickness of cortical
layers. (A) Quantification of NeuN-positive neurons in cortical layers (I, II/
III, IV, V, and VI). (B) Quantification of cortical layer thickness (I, II/III, IV, V,
and VI). In both A & B, results are presented as a percentage of controls
(wild-type rats). Errors bars represent mean ± SEM (n = 4 per genotype).
Additional file 2: Figure S2. Neuroanatomical characterization of
VLDLR transgenic (Tg) rats at P0. Histology of the cortex, hippocampus,
and cerebellum in wild-type (Wt) and transgenic (Tg) rats at P0. Panels
show Nissl-stained sagittal sections. Results are representative of four
independent experiments. Scale bar, 500 μm.
Additional file 3: Supplementary methods. Quantitative analysis. For
the cell count in cortical layers, and measurement of cortical layer
thickness, corresponding areas were sampled randomly, according to the
optical fractionator method. NeuN-positive neurons were counted in
three-dimensional counting frames. The number of cells was counted in
the right hemisphere of every 16th section. Thickness of the individual
cortical layers (I, II/III, IV, V, VI; Figure 3B) were measured in the right
hemisphere of every 16th section. Sectioning, cell counting, and
measurement of cortical layer thickness were performed by separate
investigators who were blinded with respect to the animals’ genotype.
Data were analyzed by unpaired Student’s t tests.
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